Papers for
pharmaceutical formulation teams
Papers whose findings have a practical use for this group, as judged from the abstract. Open a paper to read what it means in practice.
Agentic system improves drug formulation success rates significantly
Evidence-Grounded Agentic Formulation Development in an Autonomous Laboratory
Abstract: Self-emulsifying drug delivery systems (SEDDS) can improve the oral bioavailability of poorly soluble drugs, but identifying high-performing formulations remains experimentally intensive. We present Andromeda 2, an agentic system that reasons over structured in-house experimental evidence and invokes computational and experimental tools to design and execute successive formulation batches. Using a miniaturized automated laboratory at a matched budget, we benchmark it against Andromeda 1, a probabilistic optimization model deployed across dozens of live development projects, and a wet-lab design-of-experiments (DoE) campaign. For paclitaxel, Andromeda 2 achieved a 50% high-performance hit rate versus 17% for Andromeda 1 and 2% for DoE, and identified 12 formulations meeting all four target product profile (TPP) objectives versus 6 and 0, respectively. Median $AUC_{10-240}$ was 70.1, 12.0, and 3.5 mg$\cdot$min/mL, while maximum AUC was comparable between Andromeda 2 and Andromeda 1. A selected full-TPP formulation achieved an apparent effective paclitaxel loading of $19 \pm 5\%$ w/w at the first FaSSIF measurement, approximately 3.3-fold higher than the 5.7% w/w loading reported for a published paclitaxel S-SEDDS. A controlled ablation showed that access to structured in-house experimental evidence increased mean AUC by 34%.
Simulation maps insulin delivery through skin using coated microneedles
Numerical Simulation of Transdermal Insulin Delivery Using a Coated Microneedle in a 2D Skin Model
Abstract: In this work, we present a computational model to investigate transdermal insulin delivery using coated microneedles. A detailed skin geometry incorporating a coated microneedles was developed to analyze insulin release through the different skin layers and to evaluate the influence of key transport parameters. The model represents the major skin layers: the stratum corneum, viable epidermis, and dermis. Unstructured grids were used to achieve a reliable resolution of the model. The simulations provide insights into the permeation of insulin from the coated microneedles and the transport and distribution across the different skin layers. Finally, the simulation results were compared with experimental data to evaluate the predictive capability of the model.
Language model improves multi-goal chemical reaction optimisation
Dynamic language model representations for multi-objective reaction optimisation
Abstract: Optimising chemical reactions across multiple objectives, such as yield, selectivity, and safety, is central to chemical synthesis, and model-driven approaches depend critically on how reaction components are represented. Established featurisations are either chemically uninformative, as with one-hot encodings, or, as with molecular descriptors, do not readily extend across chemically distinct components. For structurally and functionally diverse components, it is therefore unclear what a shared representation should contain. Constructing such a representation is itself a challenging research undertaking that must be revisited for each new reaction system. Here we bypass this step by learning the reaction representation dynamically from text. Textual descriptions of reaction conditions are encoded by a fine-tuned language model trained jointly with Gaussian process surrogates, yielding task-adaptive representations within a multi-objective Bayesian optimisation loop. Across nickel- and palladium-catalysed cross-couplings in both sequential and parallel experimentation regimes, this approach reaches optimisation convergence in fewer experiments than descriptor libraries or one-hot encoding. Applied prospectively to a palladium-catalysed cyanation spanning mixed ligand denticity and heterogeneous additives, and to a three-objective asymmetric hydrogenation across chiral iridium and ruthenium catalyst families, two rounds of high-throughput experimentation (192 reactions, under 3% of each design space) delivered conditions translating directly to gram scale in 94% and 84% isolated yield, the latter at 99.6% enantiomeric excess.